Vaccines and Related Biological Products Advisory Committee

  Рет қаралды 1,947

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

The committee will meet in open session to discuss considerations related to the use of pertussis controlled human infection models [CHIMs] in pivotal studies to demonstrate effectiveness of pertussis vaccines for the purpose of licensure.

Пікірлер
FDA Clinical Investigator Training Course (CITC) 2024 - Day Two - Session Two
2:23:52
U.S. Food and Drug Administration
Рет қаралды 545
January 10, 2025 Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) Meeting
7:49:20
U.S. Food and Drug Administration
Рет қаралды 1,6 М.
БАБУШКА ШАРИТ #shorts
0:16
Паша Осадчий
Рет қаралды 4,1 МЛН
Vaccines and Related Biological Products Advisory Committee - 9/17/2021
8:09:40
U.S. Food and Drug Administration
Рет қаралды 1,6 МЛН
Modeling and Simulation to Select Oncology Dosages - Session 1
1:28:43
U.S. Food and Drug Administration
Рет қаралды 2 М.
Healthier Choices Made Easier: Proposed Front-of-Package Nutrition Info Box
0:29
U.S. Food and Drug Administration
Рет қаралды 1,6 М.
VIRTUAL PRESS CONFERENCE: FDA’s Proposed Rule on Reducing Nicotine Levels - 1/15/2025
20:43
U.S. Food and Drug Administration
Рет қаралды 1,3 М.
Cervical Cancer Treatment Innovation: A Collaborative Discussion
1:04:05
U.S. Food and Drug Administration
Рет қаралды 607
MEDIA CALL: Front of Package Nutrition Labels - 1/14/2025
19:15
U.S. Food and Drug Administration
Рет қаралды 720
Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018
44:31
FDA Clinical Investigator Training Course (CITC) 2024 - Day One - Session One
2:14:51
U.S. Food and Drug Administration
Рет қаралды 874